{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:59Z","timestamp":1793225339695,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-06042-8","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T04:52:36Z","timestamp":1764651156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dermatomyositis and microscopic polyangiitis overlap: a case-based review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9528-0583","authenticated-orcid":false,"given":"Nikolaos","family":"Zintziovas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-8205","authenticated-orcid":false,"given":"Achilleia-Maria","family":"Pavlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6325-8649","authenticated-orcid":false,"given":"Melina","family":"Yerolatsite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5332-9318","authenticated-orcid":false,"given":"Nafsika","family":"Gerolymatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-2284","authenticated-orcid":false,"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"2","key":"6042_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/BOR.0000000000001076","volume":"37","author":"F Duremala","year":"2025","unstructured":"Duremala F, Tiniakou E, Andrews J (2025) Epidemiology of myositis. Curr Opin Rheumatol 37(2):121\u2013127. https:\/\/doi.org\/10.1097\/BOR.0000000000001076","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"6042_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/imj.15358","volume":"51","author":"C Ashton","year":"2021","unstructured":"Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M (2021) Idiopathic inflammatory myopathies: a review. Intern Med J 51(6):845\u2013852. https:\/\/doi.org\/10.1111\/imj.15358. Jun. 2021","journal-title":"Intern Med J"},{"issue":"12","key":"6042_CR3","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE et al (2017) 2017 European league against Rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6042_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41584-024-01111-x","volume":"20","author":"AGS Oldroyd","year":"2024","unstructured":"Oldroyd AGS et al (2024) Author correction: international guideline for idiopathic inflammatory Myopathy-Associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative. Nat Rev Rheumatol 20(5):315\u2013315. https:\/\/doi.org\/10.1038\/s41584-024-01111-x","journal-title":"Nat Rev Rheumatol"},{"key":"6042_CR5","doi-asserted-by":"publisher","unstructured":"Gaspar BL (2023) Overlap myositis in Immune-Mediated myopathies and neuropathies. 101\u2013102. https:\/\/doi.org\/10.1007\/978-981-19-8421-1_6","DOI":"10.1007\/978-981-19-8421-1_6"},{"issue":"6","key":"6042_CR6","doi-asserted-by":"publisher","first-page":"103099","DOI":"10.1016\/j.autrev.2022.103099","volume":"21","author":"C Coustal","year":"2022","unstructured":"Coustal C et al (2022) Sj\u00f6gren syndrome overlapping with ANCA-associated vasculitis: four additional cases and systematic literature review. Autoimmun Rev 21(6):103099. https:\/\/doi.org\/10.1016\/j.autrev.2022.103099","journal-title":"Autoimmun Rev"},{"issue":"4","key":"6042_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12026-022-09279-8","volume":"70","author":"D Faz-Mu\u00f1oz","year":"2022","unstructured":"Faz-Mu\u00f1oz D et al (2022) ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review. Immunol Res 70(4):550\u2013559. https:\/\/doi.org\/10.1007\/s12026-022-09279-8","journal-title":"Immunol Res"},{"issue":"4","key":"6042_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/09612033221084519","volume":"31","author":"JD Botero","year":"2022","unstructured":"Botero JD B et al (2022) Systemic lupus erythematosus\/ANCA-associated vasculitis overlap: an explanation for atypical lupus manifestation. Lupus 31(4):495\u2013499. https:\/\/doi.org\/10.1177\/09612033221084519","journal-title":"Lupus"},{"key":"6042_CR9","doi-asserted-by":"publisher","unstructured":"Greco A et al (Sep. 2015) Microscopic polyangiitis: advances in diagnostic and therapeutic approaches. Autoimmun Rev 14(9):837\u2013844. https:\/\/doi.org\/10.1016\/j.autrev.2015.05.005","DOI":"10.1016\/j.autrev.2015.05.005"},{"issue":"9","key":"6042_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s11926-024-01154-9","volume":"26","author":"J Rathmann","year":"2024","unstructured":"Rathmann J, Mohammad AJ (2024) Classification criteria for ANCA associated Vasculitis \u2013 Ready for prime time? Curr Rheumatol Rep 26(9):332\u2013342. https:\/\/doi.org\/10.1007\/s11926-024-01154-9","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"6042_CR11","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/jcm11092573","volume":"11","author":"R Redondo-Rodriguez","year":"2022","unstructured":"Redondo-Rodriguez R, Mena-V\u00e1zquez N, Cabezas-Lucena AM, Manrique-Arija S, Mucientes A, Fern\u00e1ndez-Nebro A (2022) Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J Clin Med 11(9):2573. https:\/\/doi.org\/10.3390\/jcm11092573","journal-title":"J Clin Med"},{"issue":"3","key":"6042_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","volume":"81","author":"R Suppiah","year":"2022","unstructured":"Suppiah R et al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 81(3):321\u2013326. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221796","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6042_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40001-021-00500-2","volume":"26","author":"R Wu","year":"2021","unstructured":"Wu R, Su J, Zou Y, Zhu J (2021) ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review. Eur J Med Res 26(1):30. https:\/\/doi.org\/10.1186\/s40001-021-00500-2","journal-title":"Eur J Med Res"},{"issue":"8","key":"6042_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00296-024-05631-3","volume":"44","author":"A Masiak","year":"2024","unstructured":"Masiak A, Jassem E, D\u0119bska-\u015alizie\u0144 A, Bu\u0142\u0142o-Piontecka B, Kowalska B, Chmielewski M (2024) Co-existence of ANCA\u2013associated vasculitides with immune-mediated diseases: a single-center observational study. Rheumatol Int 44(8):1521\u20131528. https:\/\/doi.org\/10.1007\/s00296-024-05631-3","journal-title":"Rheumatol Int"},{"issue":"40","key":"6042_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10157-011-0432-2","volume":"15","author":"H Kawai","year":"2011","unstructured":"Kawai H et al (2011) Myeloperoxidase-antineutrophil cytoplasmic antibody-related crescentic glomerulonephritis after treatment for clinically amyopathic dermatomyositis: a coincidental combination or not? Clin Exp Nephrol 15,(40):577\u2013581. https:\/\/doi.org\/10.1007\/s10157-011-0432-2","journal-title":"Clin Exp Nephrol"},{"issue":"30","key":"6042_CR16","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.3346\/jkms.2024.39.e225","volume":"39","author":"IC Benlidayi","year":"2024","unstructured":"Benlidayi IC, Gupta L (2024) CAse-BAsed review sTandards (CABARET): considerations for Authors, Reviewers, and editors. J Korean Med Sci 39(30):e225. https:\/\/doi.org\/10.3346\/jkms.2024.39.e225","journal-title":"J Korean Med Sci"},{"issue":"5","key":"6042_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/mus.24566","volume":"51","author":"AR Findlay","year":"2015","unstructured":"Findlay AR, Goyal NA, Mozaffar T (2015) An overview of polymyositis and dermatomyositis. Muscle Nerve 51(5):638\u2013656. https:\/\/doi.org\/10.1002\/mus.24566","journal-title":"Muscle Nerve"},{"key":"6042_CR18","doi-asserted-by":"publisher","unstructured":"Lilleker JB et al (2024) 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands, Neuromuscular Disorders, (37):36\u201351. https:\/\/doi.org\/10.1016\/j.nmd.2024.03.001","DOI":"10.1016\/j.nmd.2024.03.001"},{"issue":"3","key":"6042_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/art.41986","volume":"74","author":"JC Robson","year":"2022","unstructured":"Robson JC et al (2022) 2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Arthritis Rheumatol 74(3):393\u2013399. https:\/\/doi.org\/10.1002\/art.41986","journal-title":"Arthritis Rheumatol"},{"issue":"21","key":"6042_CR20","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.3390\/jcm12216748","volume":"12","author":"JW Ha","year":"2022","unstructured":"Ha JW, Park Y-B, Lee S-W (2022) Overlap syndrome consisting of Polymyositis\/Dermatomyositis and ANCA-Associated vasculitis according to the 2022 ACR\/EULAR criteria for vasculitis: A Korean Single-Centre study. J Clin Med 12(21):6748. https:\/\/doi.org\/10.3390\/jcm12216748. Oct. 2023","journal-title":"J Clin Med"},{"issue":"3","key":"6042_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/03009742.2017.1334815","volume":"47","author":"S Yamada","year":"2018","unstructured":"Yamada S et al (2018) A case of inclusion body myositis complicated by microscopic polyangiitis. Scand J Rheumatol 47(3):243\u2013245. https:\/\/doi.org\/10.1080\/03009742.2017.1334815","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"6042_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5152\/eurjrheum.2017.17008","volume":"4","author":"EM Bauer","year":"2019","unstructured":"Bauer EM, Brahn E (2019) Microscopic polyangiitis with dermatomyositis. Eur J Rheumatol 4(4):291\u2013293. https:\/\/doi.org\/10.5152\/eurjrheum.2017.17008","journal-title":"Eur J Rheumatol"},{"issue":"12","key":"6042_CR23","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/1756-185X.13142","volume":"20","author":"PK Panda","year":"2017","unstructured":"Panda PK, Suri TM, Sood R, Bhalla AS, Sharma MC, Ranjan P (2017) Overlap syndrome: juvenile dermatomyositis and perinuclear antineutrophil cytoplasmic autoantibody vasculitis, a case report and review of literature. Int J Rheum Dis 20(12):2219\u20132224. https:\/\/doi.org\/10.1111\/1756-185X.13142","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"6042_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ckj\/sft142","volume":"7","author":"C Yuste","year":"2014","unstructured":"Yuste C et al (2014) Overlap between dermatomyositis and ANCA vasculitides. Clin Kidney J 7(1):59\u201361. https:\/\/doi.org\/10.1093\/ckj\/sft142","journal-title":"Clin Kidney J"},{"key":"6042_CR25","doi-asserted-by":"publisher","unstructured":"Gupta R, Kumar S, Gow P, L. (Hsien-Cheng) Chang, and, Yen L (2020) Anti\u2010MDA5\u2010associated dermatomyositis, Intern Med J, 50(4):484\u2013487. https:\/\/doi.org\/10.1111\/imj.14789","DOI":"10.1111\/imj.14789"},{"issue":"6","key":"6042_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/BOR.0000000000000908","volume":"34","author":"E Fuzzi","year":"2022","unstructured":"Fuzzi E et al (2022) Anti-MDA5 dermatomyositis: an update from bench to bedside. Curr Opin Rheumatol 34(6):365\u2013373. https:\/\/doi.org\/10.1097\/BOR.0000000000000908","journal-title":"Curr Opin Rheumatol"},{"key":"6042_CR27","doi-asserted-by":"publisher","first-page":"106134","DOI":"10.1016\/j.rmed.2020.106134","volume":"172","author":"X Xing","year":"2020","unstructured":"Xing X, Li A, Li C (2020) Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis. Respir Med 172:106134. https:\/\/doi.org\/10.1016\/j.rmed.2020.106134","journal-title":"Respir Med"},{"issue":"11","key":"6042_CR28","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","volume":"61","author":"X Gui","year":"2022","unstructured":"Gui X et al (2022) Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology 61(11):4570\u20134578. https:\/\/doi.org\/10.1093\/rheumatology\/keac090","journal-title":"Rheumatology"},{"issue":"2","key":"6042_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3899\/jrheum.220139","volume":"50","author":"C Lv","year":"2023","unstructured":"Lv C et al (2023) Coexistence of Anti-Ro52 antibodies in Anti-MDA5 Antibody\u2013Positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk. J Rheumatol 50(2):219\u2013226. https:\/\/doi.org\/10.3899\/jrheum.220139","journal-title":"J Rheumatol"},{"issue":"1","key":"6042_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-023-03100-z","volume":"25","author":"H Wang","year":"2023","unstructured":"Wang H et al (2023) Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody. Arthritis Res Ther 25(1):127. https:\/\/doi.org\/10.1186\/s13075-023-03100-z","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"6042_CR31","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/rheumatology\/keaa786","volume":"60","author":"A Xu","year":"2021","unstructured":"Xu A et al (2021) Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Rheumatology 60(7):3343\u20133351. https:\/\/doi.org\/10.1093\/rheumatology\/keaa786","journal-title":"Rheumatology"},{"key":"6042_CR32","doi-asserted-by":"publisher","unstructured":"Xiao F et al (2025) )Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model. Ann Med 57(1). https:\/\/doi.org\/10.1080\/07853890.2024.2440621","DOI":"10.1080\/07853890.2024.2440621"},{"issue":"3","key":"6042_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10067-022-06401-x","volume":"42","author":"DC Quintero-Gonz\u00e1lez","year":"2023","unstructured":"Quintero-Gonz\u00e1lez DC, Navarro-Bele\u00f1o K, L\u00f3pez-Guti\u00e9rrez LV, Mu\u00f1oz-Urbano M, Vanegas-Garc\u00eda A-L, Mu\u00f1oz-Vahos CH (2023) Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review. Clin Rheumatol 42(3):949\u2013958. https:\/\/doi.org\/10.1007\/s10067-022-06401-x","journal-title":"Clin Rheumatol"},{"issue":"7","key":"6042_CR34","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1253\/circj.CJ-19-1046","volume":"84","author":"H Kawano","year":"2020","unstructured":"Kawano H, Kinoshita N, Izumida S, Shimizu T, Umeda M, Maemura K (2020) Myocarditis in a patient with clinically amyopathic dermatomyositis. Circ J 84(7):1194. https:\/\/doi.org\/10.1253\/circj.CJ-19-1046","journal-title":"Circ J"},{"key":"6042_CR35","doi-asserted-by":"publisher","unstructured":"Zhou S et al (2022) Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis\/clinically amyopathic dermatomyositis: a retrospective study. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.928861","DOI":"10.3389\/fimmu.2022.928861"},{"issue":"1","key":"6042_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11926-023-01123-8","volume":"26","author":"M Sayer","year":"2024","unstructured":"Sayer M, Chapman GB, Thomas M, Dhaun N (2024) Cardiovascular disease in Anti-neutrophil cytoplasm Antibody-Associated vasculitis. Curr Rheumatol Rep 26(1):12\u201323. https:\/\/doi.org\/10.1007\/s11926-023-01123-8","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"6042_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3899\/jrheum.190569","volume":"46","author":"C-R WANG","year":"2019","unstructured":"WANG C-R, TSAI Y-S, TSAI H-W (2019) Acute myocarditis in patients with antineutrophil cytoplasmic Antibody\u2013positive microscopic polyangiitis and receiving rituximab therapy. J Rheumatol 46(12):1645\u20131646. https:\/\/doi.org\/10.3899\/jrheum.190569","journal-title":"J Rheumatol"},{"issue":"9","key":"6042_CR38","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","volume":"19","author":"S Moiseev","year":"2020","unstructured":"Moiseev S et al (2020) 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev 19(9):102618. https:\/\/doi.org\/10.1016\/j.autrev.2020.102618","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6042_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B et al (2024) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 83(1):30\u201347. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6042_CR40","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-2133.2004.06144.x","volume":"151","author":"M Caproni","year":"2004","unstructured":"Caproni M et al (2004) Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 151(4):784\u2013791. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06144.x","journal-title":"Br J Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-06042-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:14:02Z","timestamp":1771427642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-06042-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6042"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-06042-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the University Hospital of Ioannina (Protocol code: 657\/3-9-2025).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the participant included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Participant provided consent for publication of the study findings.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1"}}